What the research found

A systematic review of literature on how menopause appears in electronic health records identified only 19 studies addressing this question—a striking scarcity. The researchers found that menopause status, reproductive stage, and symptom documentation remain highly inconsistent across health systems. Rather than being recorded directly, menopause is often inferred indirectly from age, diagnosis codes, or whether a patient received hormone therapy. When diagnosis codes were used, most studies didn't even report which specific codes they selected, making comparison between health systems nearly impossible.

The review also uncovered a gap between documentation and action: symptoms were sometimes recorded but treatment didn't follow. This fragmentation matters because it means anyone falling outside a simple profile—such as someone who became postmenopausal early, uses a hormonal IUD, is on hormone therapy for another reason, or has had a hysterectomy—is at risk of being missed entirely by the medical system.

Why it matters for you

If you're tracking biomarkers, protocols, or treatment responses through MyKine, you're doing something most health systems don't: creating a coherent, longitudinal record of your own data. For women in midlife, this becomes especially important. Menopause symptoms—sleep disruption, hot flashes, joint pain, mood changes, cognitive fog—often get fragmented across different doctors' notes and attributed to separate problems rather than understood as part of a coherent transition.

When you log your symptoms, their timing, and how interventions (whether HRT, supplements, or lifestyle changes) affect your biomarkers and daily function, you're building a dataset that your own clinician can actually use. This matters for treatment decisions: understanding whether your blood pressure elevation or lipid shifts correlate with your reproductive stage, or whether a supplement or protocol you've tried genuinely moved your markers and symptoms together, requires the kind of structured tracking that most medical records don't provide.

As AI tools increasingly advise on health management, they inherit the blind spots of the data they're trained on. A fragmented medical record means AI systems may miss patterns that become obvious once menopause context is added.

Caveats

• Limited evidence base: Only 19 studies exist on this topic; the review itself is descriptive rather than providing new primary data
• Mostly US-focused: The included studies were predominantly conducted in US health systems; patterns may differ elsewhere
• No new experimental data: This is a survey of existing documentation practices, not a clinical trial or mechanistic study
• Structural rather than clinical: The problem identified is about how data is recorded and organized, not about the biology of menopause itself